China Approves HIV Drug for COVID Patients

July 25th, 2022

Via: Reuters:

China on Monday gave conditional approval to domestic firm Genuine Biotech’s Azvudine pill to treat certain adult patients with COVID-19, adding another oral treatment option against the coronavirus.

Leave a Reply

You must be logged in to post a comment.